References
1. Peterson PB, WiUard MD. Protein-losing enteropathies. Vet Clin SmallAnim 2003; 33: 1061-1082.
2. Fossum TW Protein-losing enteropathy. Sem Vet Med Surg 1989; 4: 219-225.
3.
Suter MM, Palmer DG, Schenk H. Primary intestinal lymphangiectasia in three dogs: a morphological and immunopatholgical investigation. Vet Pathol 1985; 22: 123-130.4. Fossum TW, Sherding RG, Zach PM et al. Intestinal lymphagiectasia associated with chylothorax in two dogs.JAm Vet Med Assoc 1987; 190: 61-64.
5. Van Kruiningen HJ, Lees GE, Hayden DW et al. Lipogranulomatous lymphangitis in canine intestinal lymphagiectasia. Vet Pathol 1984; 21: 377-383.
16. Kim KE. Protein-losing gastroenteropathy. In: Feldman M, Scharschmidt BF, Sleisenger MH (eds.), Sleisenger & Fordtran' Gastrointestinal and Liver Disease Pathophysiology/Diagnosis/ Management, 7th ed. Philadelphia, WB Saunders, 2002; 446-375.
17. Kimmel SE, Waddell LS, Michel KE. Hypomagnesemia and hypocalcemia associated with protein-losing enteropathy in Yorkshire Terriers: Five cases (1992-1998). J Am Vet Med Assoc 2000; 217: 703-706.
18. Littman MP, Dambach DM, Vaden SL et al. Familial protein-losing enteropathy and/or protein-losing nephropathy in Soft-Coated Wheaten Terriers: 222 cases (1983-1997). J Vet Intern Med 2000; 14: 68-80.
9. Murphy KF, German AJ, Ruaux CG et al. Fecal U1-proteinase inhibitor concentration in dogs with chronic gastrointestinal disease. Vet Clin Path 2003; 32: 67-72.
10. Steiner JM, Ruaux CG, Miller MD et al. Intra-individual variability of fecal U1-proteinase inhibitor concentration in clinically healthy dogs.J Vet Intern Med 2003; 17: 445 (Abstract).
11. Willard MD, Lovering SL, Cohen ND et al. Quality of tissue specimens obtained endoscopically from the duodenum of dogs and cats. JAm Vet Med Assoc 2001; 219: 474-479.
12. Zoran DL. Nutritional management of gastrointestinal conditions. In: Ettinger SJ, Feldman EC (eds.), Textbook of Veterinary Internal Medicine, 6th ed. St. Louis, Elsevier Saunders 2005; 570-573.
13. Falth-Magnusson K, Kjellman NI et al. Intestinal permeability in healthy and allergic children before and after sodium cromoglycate treatment assessed with different sized polyethylene glycols. Clin Al- Iergy 1984; 14: 277-286.
14. Sogn D. Medications and their use in the treatment of adverse reactions to foods. J Allergy Clin Immunol 1986; 78: 238-243.
5.3.10